From a neurological perspective, inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a relevant target in the management of neurodegenerative conditions such as Alzheimer’s disease. The gene discussed is ACHE; the disease is Alzheimer disease.